|
Human Gene Therapy
Retroviral Gene Transfer to Human Epidermal Keratinocytes Correlates with Integrin Expression and Is Significantly Enhanced on Fibronectin
To cite this article:
Bharat Bajaj, Shahram Behshad, Stelios T. Andreadis.
Human Gene Therapy.
October 2002,
13(15): 1821-1831.
doi:10.1089/104303402760372927.
Bharat Bajaj Bioengineering Laboratory, Department of Chemical Engineering, University at Buffalo, State University of New York, Amherst, NY 14260. Shahram Behshad Bioengineering Laboratory, Department of Chemical Engineering, University at Buffalo, State University of New York, Amherst, NY 14260. Stelios T. Andreadis Bioengineering Laboratory, Department of Chemical Engineering, University at Buffalo, State University of New York, Amherst, NY 14260. Human epidermal keratinocytes are an important target for gene therapy because they can be easily expanded in culture and used to generate skin substitutes for the treatment of wounds, genetic diseases of the skin, and for delivery of proteins to the systemic circulation. Although retroviral transduction results in permanent genetic modification, differentiation and loss of transduced cells from the epidermis results in temporary transgene expression. To ensure permanent genetic modification, epidermal stem cells must be transduced with high efficiency. We evaluated gene transfer on two different substrates and found that the efficiency of gene transfer is substantially higher on a substrate of recombinant fibronectin (FN), when compared to tissue culture plastic (TCP). The rate of retroviral transduction on FN is four times faster than transduction on tissue culture plates and is independent of polybrene (PB). The transduction efficiency correlates with the levels of expression of integrin subunits α5, α2, and β1, which have been shown to correlate with stem cell phenotype. Notably, cells that adhere rapidly to FN are transduced more efficiently than slowly adherent cells. In addition, integrin-blocking antibodies decrease the efficiency of gene transfer in a dose-dependent manner. Our results suggest that FN may enhance retroviral gene transfer to the least differentiated cells, thereby increasing the potential of genetically modified keratinocytes to treat short- and long-term disease states.  This paper was cited by:Safe Selection of Genetically Manipulated Human Primary Keratinocytes with Very High Growth Potential Using CD24 Valérie Bergoglio, Fernando Larcher, Odile Chevallier-Lagente, Alain Bernheim, Olivier Danos, Alain Sarasin, Marcela Del Rio, Thierry Magnaldo Molecular Therapy. Jan 2008, Vol. 15, No. 12: 2186-2193 CrossRef EGF Receptor Activation Decreases Retroviral Gene Transfer through Protein Kinase C-δ Raghvendra Singh, Stelios T Andreadis Molecular Therapy. Mar 2007, Vol. 15, No. 2: 369-377 CrossRef Stoichiometric limitations in assembly of active recombinant retrovirus Pedro Lei, Stelios T. Andreadis Biotechnology and Bioengineering. Jul 2005, Vol. 90, No. 7: 781-792 CrossRef In Vivo Model of Wound Healing Based on Transplanted Tissue-Engineered Skin David J. Geer, Daniel D. Swartz, Stelios T. Andreadis Tissue Engineering. Jul 2004, Vol. 10, No. 7-8: 1006-1017 Abstract | Full Text PDF | Reprints & PermissionsGene transfer to epidermal stem cells: implications for tissue engineering Stelios T Andreadis Expert Opinion on Biological Therapy. Jul 2004, Vol. 4, No. 6: 783-800 CrossRef
|
|